🔗 Share this article

This year's prestigious award in medical science was granted for transformative findings that clarify how the immune system targets dangerous pathogens while sparing the healthy tissues.

Three esteemed scientists—Japan's Shimon Sakaguchi and US experts Dr. Brunkow and Dr. Ramsdell—received this accolade.

The research identified unique "sentinels" within the immune system that eliminate rogue immune cells that could attacking the body.

These discoveries are now paving the way for new treatments for immune disorders and malignancies.

These laureates will divide a prize fund valued at 11 million Swedish kronor.

Decisive Discoveries

"The research has been decisive for comprehending how the immune system operates and the reason we do not all suffer from severe self-attack conditions," commented the head of the Nobel Committee.

The team's studies address a fundamental mystery: How does the defense system protect us from countless infections while keeping our own tissues unharmed?

Our body's protection system employs white blood cells that search for indicators of disease, including pathogens and germs it has never encountered.

Such defenders employ sensors—called receptors—that are produced by chance in a vast number of variations.

This provides the immune system the capacity to fight a wide array of invaders, but the randomness of the mechanism inevitably produces white blood cells that can target the body.

Security Guards of the Body

Researchers previously knew that some of these problematic white blood cells were destroyed in the immune organ—where white blood cells mature.

The latest Nobel Prize honors the identification of T-reg cells—described as the immune system's "peacekeepers"—which patrol the body to disarm any immune cells that assault the healthy cells.

We know that this mechanism malfunctions in self-attack conditions such as type-1 diabetes, multiple sclerosis, and rheumatoid arthritis.

A Nobel panel added, "These findings have laid the foundation for a new field of research and accelerated the creation of innovative therapies, for example for tumors and immune disorders."

Regarding malignancies, T-regs block the body from fighting the tumor, so research are aimed at lowering their numbers.

For autoimmune diseases, experiments are testing increasing T-reg cells so the organism is no longer being harmed. A comparable approach could also be useful in reducing the chances of transplanted organ failure.

Pioneering Studies

Prof Sakaguchi, from Osaka University, conducted experiments on rodents that had their immune gland extracted, leading to autoimmune disease.

He showed that injecting immune cells from healthy mice could prevent the disease—implying there was a system for blocking defenders from attacking the body.

Mary Brunkow, affiliated with the a research center in Seattle, and Dr. Ramsdell, currently at Sonoma Biotherapeutics in a California city, were studying an genetic immune disorder in mice and people that resulted in the identification of a genetic factor vital for the way T-regs operate.

"Their groundbreaking work has uncovered how the body's defenses is kept in check by T-reg cells, stopping it from mistakenly attacking the body's own tissues," commented a leading biological science expert.

"The research is a striking illustration of how fundamental biological study can have broad implications for human health."